SUMMARY One hundred and fifty two patients with chronic heart failure caused primarily by left ventricular dysfunction were followed prospectively in an open study for a mean period of 21 months. The effects of several clinical variables on subsequent outcome were examined, including the effects of treatment, which was determined by the clinician caring for the patient and was not randomly allocated. In order of importance, frequent ventricular extrasystoles, non-treatment with amiodarone, low mean arterial pressure, and a diagnosis of coronary artery disease were associated with a poor prognosis, with each of these variables providing extra predictive information independently of the others. Initial serum potassium concentration and treadmill exercise time also carried further weak but independent prognostic information. Neither treatment with angiotensin converting enzyme inhibitors nor digoxin appeared to affect outcome. Left ventricular function (as reflected by M mode echocardiography) and the dose of diuretic also failed to predict outcome. There did, however, appear to be a reduction in the frequency of sudden death when angiotension converting enzyme inhibitors were given.
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Further studies are required to confirm the adverse prognostic significance of ventricular arrhythmias in patients with heart failure and the possible benefit associated with amiodarone treatment.
Chronic heart failure is a condition of varied aetiology that imposes a heavy burden of symptoms, confers a very poor prognosis, 13 and affects 4% of the population under the age of 75 years. 4 Once an in-hospital diagnosis of heart failure has been made, the annual mortality is likely to be 40% or more,1 1 3 though the prognosis seems to be slightly better in those patients not referred to hospital and who, presumably, have milder disease.
The most frequently reported mode of death in patients with heart failure seems to be sudden,2 3 5 presumably caused by ventricular arrhythmias,6 which are common. ' 7 8 Many' 9 10 but not all" -1 3 workers suggest that these arrhythmias are powerful independent prognostic indicators for mortality. Whether Accepted for publication 21 July 1987 unclear at present. '10 13 One retrospective casecontrol study suggested no reduction in mortality with procainamide,'4 though anecdotal comment has suggested a possible benefit with amiodarone. '5 Another prospective study suggested that arrhythmias in patients with heart failure are resistant to treatment.'6 "Vasodilator" treatment on the other hand has been shown to improve outcome.' 7 18 Mortality in heart failure: clinical variables of prognostic value years, 84% were male, and the mean (SD) duration of heart failure was 18 (19) months (all > 3 months). One hundred and four had received digoxin for more than one month before entry to the study and all were receiving frusemide in a mean (1 SD) daily dose of 127 (85) mg/day. No patients were on potassium-sparing diuretics but 47 were on potassium chloride supplements (median dose 1800 mg/day). The The mean initial heart rate was 88 (14) beats/min and mean arterial pressure was 91 (14) mm Hg. Forty five patients (30%) had left bundle branch block. The mean concentration of serum sodium was 136 + 10 mmol/l, of serum potassium 3-8 (0O4) mmol/l, and of serum creatinine 117 (27) imol/l. The mean end diastolic left ventricular dimension was 6 7 (0 8) cm and end systolic dimension was 5-7 (0 9) cm. The resulting fractional shortening was 15 3 (6 5)%.
CHANGES IN TREATMENT
During follow up 11 patients were started on nitrate treatment, one on prazosin, and three on hydralazine. In 18 patients an increase in diuretic treatment was required, and in six patients-who were taking angiotensin converting enzyme inhibitors the dose of diuretic was reduced because of postural hypotension. As mentioned above four patients-were treated with antiarrhythinic agents for sustained ventricular tachycardia at a time other than entry to the study. Nineteen patients were taking potassiumsparing diuretics: amiloride in 14 (10-20 mg/day) and spironolactone in five (25-50 mg/day). Only three of these were in the group treated with angiotensin converting enzyme inhibitors.
COMPARISON OF TREATMENT SUBGROUPS
Those treated with amiodarone were well matched in all respects with those who did not receive this treatment (table 1) . Those subjects treated with angiotensin converting enzyme inhibitors (table 2) had significantly worse New York Heart Association scores, tended to have shorter exercise times, more episodes of ventricular tachycardia, and required significantly more frusemide and digoxin.
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RELATION OF MEAN ARTERIAL PRESSURE TO OTHER MEASURED VARIABLES
The set of variables with the best independent relation to mean arterial pressure was serum sodium (r = 0-54 p < 0 001), New York Heart Association score (r = -0 41 p < 0 001), and end diastolic left ventricular dimension (r = -0-29 p < 0 01). 
RELATION OF SERUM POTASSIUM AND EXERCISE TIME TO OTHER MEASURED VARIABLES
Only serum sodium (r = 0O40 p < 0-001) was found to have a significant and independent relation to serum potassium. Exercise time was best related on stepwise regression to New York Heart Association score (r = -079; p < 0-0001) and fractional shortening (r = 031; p < 0-001).
ESTIMATED SURVIVAL CURVES
The estimated survival curves for amiodarone versus no amiodarone treatment again suggested significant improvement in survival with amiodarone ( fig 4) . The estimated survival curves still suggested no pronounced beneficial effect with angiotensin converting enzyme inhibitors (fig 5) , but also suggested no deleterious effect with digoxin use.
The estimated survival curves for prognostic indicators suggested that clinically meaningful separation could be made on the basis of the frequency of ventricular extrasystoles (fig 6) , a diagnosis of coronary artery disease (fig 7) , mean arterial pressure (fig 8), exercise time (fig 9) , and serum potassium (fig 10) . Cleland, Dargie, Ford The frequency of sudden death in this study is higher than the figure of around 50% reported in some studies. This may reflect differences in both the chosen patient population and differences in reporting. Other investigators have tended to exclude from the sudden death group patients with some deterioration in their condition before death, though the terminal event may none the less have been sudden, unexpected, and potentially arrhythmic. On the other hand we have adopted a very rigid definition of death caused by heart failure.
Our study suggests that arrhythmias are more closely related to functional class and exercise performance than to indices of resting left ventricular performance. The lack of a relation between prognosis and M mode echocardiographic measurements of left ventricular function should be interpreted with caution especially when comparing different subjects with ventricles that have been damaged by ischaemia. However, several studies with invasive haemodynamics have also suggested a poor relation with prognosis.2" The relatively poor relation of exercise performance to left but not to right ventric- patients with heart failure.2 12 25 Left bundle branch block5 26 serum sodium concentration,3 27 mean arterial pressure,2 exercise performance,28 and central venous plasma noradrenaline concentration3 have also been found to be useful in some studies.
But for each of these indices there are conflicting studies. 29 -31 This study clearly demonstrates that the frequency of ventricular extrasystoles is strongly associated with a poor prognosis in patients with chronic heart failure caused by left ventricular dysfunction. That death is due to ventricular arrhythmias cannot be proved in a study like this one, but the high frequency of sudden death and low frequency of death caused by intractable heart failure suggest that the great majority of deaths in such patients are the result of arrhythmias. The lack of a significant relation between more complex ventricular arrhythmias and mortality may reflect the relatively short period over which we recorded the electrocardiogram. We have confirmed that complex ventricular arrhythmias relate closely to the frequency of simple extrasystoles, as has been previously noted. 39 We were unable to demonstrate any direct effect of therapeutic concentrations of digoxin on arrhythmias in heart failure, perhaps because of the wide interindividual susceptibility to arrhythmias or to the counterbalancing effect of an improvement in left ventricular function. 40 It is likely that local myocardial ultrastructural and metabolic factors together with focal ischaemia caused by coronary vascular disease or excessive myocardial wall tension also lead to arrhythmias; these would not have been detected by our screening methods. Increased sympathetic activity might also give rise to arrhythmias4" and because sympathetic activity appears greatest in subjects with the lowest mean arterial pressure42 this is one mechanism by which low blood pressure may be related to arrhythmias.
A low mean blood pressure was also found to be of prognostic significance, as has been noted by others.2 Plasma renin and catecholamines are known to be inversely related to blood pressure in heart failure42 and a recent study has suggested that concentrations of plasma noradrenaline and to a lesser extent plasma renin are of prognostic significance in heart failure,3 though this has been disputed.7 Our study also demonstrates the inverse relation between blood pressure and serum sodium. Low blood pressure appears also to be a marker of clinically more severe heart failure because it is associated with worse New York Heart Association scores and poorer exercise performance.
The poorer prognosis in patients with coronary artery disease noted in this and other studies2 appears related to sudden death rather than reinfarction. Transient focal ischaemia may have caused arrhythmias even though angina was not a feature of this study group. Cleland, Dargie, Ford toms, lower mean blood pressure, and lower incidence of arrhythmias in those with coronary artery disease should also be noted.
The widely divergent estimated survival curves that we found not only for amiodarone treatment, but also for the frequency of ventricular arrhythmias, the diagnosis of coronary artery disease, arterial pressure, exercise time, and serum potassium suggest that the factors we have described are of clinical relevance. These clinical variables could be used to define an individual patient's likely prognosis.
The effect of vasodilators on prognosis remains controversial,174344 while angiotension converting enzyme inhibitors appear to have beneficial effects on prognosis. 84345 Attempts have been made with antiarrhythmic drugs to improve the prognosis in heart failure. Some drugs such as disopyramide46 and flecainide47 seem to be unsuitable because of their negative inotropic action, while experience with other class I agents such as procainamide'4 has not been fruitful. Agents such as P blockers and verapamil48 49 are also negative inotropes; these also seem unsuitable for use in this area, though there is conflicting evidence of a beneficial effect of P blockers in heart failure.50 51 Depression of ventricular function by amiodarone at rest or during exercise is rare when modest doses are used.52 53 Amiodarone also effectively suppresses ventricular arrhythmias in patients with heart failure,'7 presumably accounting for the pronounced reduction in sudden death. The improvement in prognosis noted in the present study may not be entirely the result of its antiarrhythmic actions. Amiodarone also has antiischaemic effects which may be beneficial in idiopathic dilated cardiomyopathies as well as in heart failure related to coronary artery disease.
The relatively low maintenance dose of amiodarone used in this study limited the frequency of side effects. We have also noted worsening of arrhythmias in patients with heart failure when a loading dose of amiodarone of 200 mg three times a day was given. Such patients have responded to a more gradual introduction of amiodarone 100-200 mg once daily. Though the PR interval was prolonged in several patients on amiodarone we found only one case of higher grade block (2:1 block).
We were unable to demonstrate any effect on overall prognosis associated with the use of either digoxin or angiotensin converting enzyme inhibitors, nor did the dose of diuretic exert any powerful effect. The group treated with angiotensin converting enzyme inhibitors had worse heart failure, however, and the statistical analysis may not have compensated for this difference. A large controlled study has demonstrated a pronounced reduction in mortality rates in patients with very severe heart failure treated with enalapril.'8 Interestingly, in patients with severe heart failure deaths from progressive heart failure were reduced but not sudden deaths. This contrasts with the rise in mortality associated with the use of some inotropic agents in heart failure."4 In our study, the incidence of sudden death was significantly reduced in those on angiotensin converting enzyme inhibitors; this may have been attributable to correction of hypokalaemia and hypomagnesaemia and intracellular potassium depletion, beneficial haemodynamic effects, and a reduction in sympathetic activity.55 56 The statistically insignificant increase in the frequency of vascular events suggests that angiotensin converting enzyme inhibitors should be used with caution in patients with known critical arterial stenoses. Potential deleterious effects of digoxin and higher doses of diuretics may have been masked by the use of amiodarone and captopril, but they did not seem to exert any powerful influence on prognosis.
